Estrella Immunopharma (Estrella Immunopharma) Operating Cash Flow per Share : $-0.45 (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma Operating Cash Flow per Share?

Estrella Immunopharma's operating cash flow per share for the three months ended in Mar. 2024 was $-0.12. Estrella Immunopharma's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.45.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Estrella Immunopharma's Operating Cash Flow per Share or its related term are showing as below:

ESLA's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.3
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Estrella Immunopharma Operating Cash Flow per Share Historical Data

The historical data trend for Estrella Immunopharma's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Estrella Immunopharma Operating Cash Flow per Share Chart

Estrella Immunopharma Annual Data

Trend

Jun21

Operating Cash Flow per Share

-0.02

Estrella Immunopharma Quarterly Data
	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial					-	-	-0.01	-0.32	-0.12

Competitive Comparison of Estrella Immunopharma's Operating Cash Flow per Share

For the Biotechnology subindustry, Estrella Immunopharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Estrella Immunopharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Estrella Immunopharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Estrella Immunopharma's Price-to-Operating-Cash-Flow falls into.

Estrella Immunopharma Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Estrella Immunopharma's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2021 is calculated as

Operating Cash Flow per Share (A: Jun. 2021 )	=	Cash Flow from Operations (A: Jun. 2021 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2021 )
	=	-0.671	/	35.201
	=	-0.02

Estrella Immunopharma's Operating Cash Flow per Share for the quarter that ended in Jun. 2021 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-4.235	/	35.519
	=	-0.12

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.45

Estrella Immunopharma Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Estrella Immunopharma (Estrella Immunopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLA) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608

Website

https://www.estrellabio.com

Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma (Estrella Immunopharma) Headlines

No Headlines